|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication April 1, 2004.
Revised August 3, 2004.
Accepted for publication August 3, 2004.
Cystic fibrosis is caused by mutations in the cystic
fibrosis transmembrane conductance regulator (CFTR)
gene, which belongs to the superfamily of ABC
transporters and uniquely possesses an additional large
cytoplasmic domain (R domain). CFTR inefficiently folds
by means of co- and post-translational interactions with
the cytosolic chaperones as well as ER lumenal
chaperones in the ER. Aberrant folding and defective
trafficking of the CFTR protein, which functions as an
apical membrane Cl- channel, is the principal cause of
cystic fibrosis. Recent data indicated that butyrate
improves CFTR trafficking, in part, by regulating
molecular chaperones. However, the precise mechanism of
butyrate action remains elusive. In the present study,
we examine the molecular aspect underlying the butyrate
action in CFTR biogenesis, by evaluating the expression
and localization of the GFP-tagged CFTR transgenes in
Cos7 cells. Our data show that butyrate significantly
promoted stability of the ER-located form of GFP-wt-
CFTR, followed by an increase in the amount of plasma
membrane GFP-wt-CFTR. In contrast, the expression of the
R domain deletion mutant, GFP-
R-CFTR, was
slightly increased by butyrate. The butyrate action on
wt-CFTR expression was partially blocked by PD98059, a
specific inhibitor of MAPKK/MEK which is the upstream
activator of ERK/MAPK. Furthermore, activation of
ERK/MAPK by coexpression of constitutively active
MAPKK/MEK predominantly augmented the expression of wt-
CFTR, but not of
R-CFTR, induced by butyrate.
These data suggest that butyrate may facilitate the
biogenesis and trafficking of wt-CFTR by requiring the
presence of the R domain, and further involving active
ERK/MAPK in its biogenesis.
Key words:
MAP Kinase, Ion transporters (SERCA, Na/K ATPase, CFTR), Regulation of gene expression, Regulation - post-transcriptional
This article has been cited by other articles:
![]() |
T. Roque, E. Boncoeur, V. Saint-Criq, E. Bonvin, A. Clement, O. Tabary, and J. Jacquot Proinflammatory Effect of Sodium 4-Phenylbutyrate in {Delta}F508-Cystic Fibrosis Transmembrane Conductance Regulator Lung Epithelial Cells: Involvement of Extracellular Signal-Regulated Protein Kinase 1/2 and c-Jun-NH2-Terminal Kinase Signaling J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 949 - 956. [Abstract] [Full Text] [PDF] |
||||